The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
Martin A. Cheever(Memorial Sloan Kettering Cancer Center), Lynn M. Matrisian(Pancreatic Cancer Action Network), Olivera J. Finn(University of Pittsburgh), Sheila A. Prindiville(Memorial Sloan Kettering Cancer Center), Louis M. Weiner(Georgetown University), James P. Allison(The University of Texas MD Anderson Cancer Center), Jaye L. Viner(Memorial Sloan Kettering Cancer Center), Ira Mellman(Genesys (United States)), Benjamin M. Hastings(Memorial Sloan Kettering Cancer Center), Andrea Stern Ferris(Memorial Sloan Kettering Cancer Center), Toby T. Hecht(Memorial Sloan Kettering Cancer Center)
Cited by 1,375
Related Papers
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
|Cancer Research|2014|7.2k
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
|Science|2002|2.7k
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
|New England Journal of Medicine|2012|2.1k
Metalloproteinases and their inhibitors in matrix remodeling
|Trends in Genetics|1990|1.6k
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
|Journal of Clinical Oncology|2000|1.6k